In cancer research, long non‑coding RNAs (lncRNAs) are emerging as critical regulators of tumorigenesis. The Cancer LncRNome Atlas (TCLA) offers a robust platform to explore how lncRNAs are altered across diverse cancer types—including expression, genomic… What TCLA Reveals About lncRNA Alterations In Cancer Research
Cancer is notoriously complex, arising from intricate interactions across multiple molecular layers. The Functional Cancer Genome (FCG) Portal offers a groundbreaking integrated omics platform by melding genomics, functionomics, and pharmacologenomics—empowering researchers to unravel the molecular… The Power Of Integrated Omics Via FCG’s Cancer Portal
Copy Number Variation (CNV) analysis is a cornerstone of cancer genomics, revealing amplifications and deletions that drive tumor behavior. The Functional Cancer Genome (FCG) Portal delivers robust CNV information drawn from TCGA datasets, enabling deeper… How To Interpret FCG’s Copy Number Variation Data
The Functional Cancer Genome (FCG) Portal has evolved significantly since 2020, enriching the cancer research community with new atlases, improved search functionality, streamlined user interface, and refined data accessibility. These updates underscore FCG’s commitment to… What’s New in the FCG Portal Since 2020?
In the evolving landscape of cancer research, identifying and understanding the role of specific proteins on the surface of cancer cells is crucial. These proteins, known as genes encoding cell surface proteins (GESPs), play a pivotal… Understanding GESPs: What Does ‘Positive Expression’ Mean in Cancer?
Functional genomics is revolutionizing cancer research by elucidating the roles of genes and their interactions in tumorigenesis. In 2025, the integration of advanced technologies and methodologies is propelling the field towards more precise and personalized… What’s Next for Functional Cancer Genome Tools?
Cancer remains a leading cause of mortality worldwide, necessitating the continuous exploration of novel biomarkers and therapeutic targets. Nuclear receptors (NRs), a family of 48 ligand-dependent transcription factors, have emerged as pivotal players in cancer biology. … Why Nuclear Receptors Offer Powerful Cancer Biomarkers and Targets
